At Standard Pharma, we apply science and global resources to provide top-quality active pharmaceutical ingredients (APIs), excipients, packaging materials, and technical services to pharmaceutical enterprises. We are committed to bringing turnkey package solutions from project initiation, to R&D and, finally, commercial production for our clients. We strive to set the standard for quality services platforms in R&D and manufacturing processes for the pharmaceutical industry in China.
Founded in 2001, Standard Pharma is headquartered in Guangzhou and has expanded with sales and technical support offices in Shanghai, Tianjin, Chongqing, and Harbin. Our warehouses and logistics centres have a total area of more than 5000 square metres in Guangzhou and Tianjin, enabling quick responses to the clients’ needs across the country.
In 2005, PIDI Standard Biotech (Chongqing) Ltd. was established in Wanzhou district in Chongqing. Standard Pharma is one of the founders and is responsible for management. PIDI Standard is an internationally recognised manufacturer of Artemisinin. The company had partnered with the Clinton Foundation, the Bill & Melinda Gates Foundation, the Global Fund, and World Health Organisation in the fight against Malaria. It is also one of the largest domestic manufacturers of N-Phenylglycine potassium salt.
Since 2001, Standard Pharma has been successfully distributing high quality imported APIs to domestic pharmaceutical enterprises. The company has partnered with Hetero, Dr. Reddy, Cipla, Lupin, Glenmark, Alkaloid, Optimus and other global API manufacturers, providing more than 400 API products.
For pharmaceutical excipients, the company is an authorised agent for international pharmaceutical excipient manufacturers such as Meggle (Germany), Gattefossé (France), Dow (USA), Merck (Germany), Fuji Silysia (Japan), JRS (Germany), Sensient (USA), Cyclolab (Hungary), Star-Tech & JRS Specialty Products Co., Ltd (SSP) and many more.
The company has been authorised to operate as an agent in the pharmaceutical packaging materials industry, by the world's leading pharmaceutical packaging materials manufacturer and original creator of PVDC, Klöckner Pentaplast (KP) from Germany.
With 20 years of experience, Standard Pharma has built a strong reputation in China’s pharmaceutical supply chain through success in optimising the supply chain for high quality pharmaceutical materials and delivery of first class technical support to more than 3000 pharmaceutical enterprises with its innovative ‘one-stop shop’ approach.
Standard Pharma firmly believes that ‘technology innovation’ is the source of power for the development of the pharmaceutical industry. The company practices the ‘technology-driven sales’ development strategy, and continues to build professionalisation in the sales team with improved technical service. The company strives to become a ‘technology-driven’ benchmark enterprise and the best partner of the global supply chain in the industry and to help develop the pharmaceutical industry in China.
△Ms. Christine Lin, the chairman of Standard Pharma, has spoken many times at international conferences on behalf of Chinese artemisinin manufacturers
Scan by Wechat
for free samples